Fortnightly Review: Management of atopic eczema

BMJ 1995;310:843-847 (1 April)

Education and debate

Fortnightly Review: Management of atopic eczema

P M McHenry, clinical lecturer,^a H C Williams, senior lecturer,^b E A Bingham, consultant dermatologist,^c on behalf of a Joint Workshop of the British Association of Dermatologists and the Research Unit of the Royal College of Physicians of London

^a Department of Dermatology, Robertson Building, University of Glasgow, Glasgow G12 8QQ, ^b Department of Dermatology, University Hospital, Queen's Medical Centre, Nottingham, ^c Department of Dermatology, Royal Victoria Hospital, Belfast

Participants in the workshop are listed at the end of the article.Correspondence to: Dr McHenry.

Summary points

Time for explanation and education is essential
Adequate amounts of emollients should be prescribed, and these should be used liberally and frequently
When prescribing topical corticosteroids the age of the patient, the site to be treated, and the extent of the disease are important considerations
Deterioration in previously stable eczema may be due to secondary bacterial or viral infection or to development of a contact dermatitis
Attempts to eradicate the house dust mite are not currently recommended
Dietary restriction is of little or no benefit in adults, and in children it is worth trying only in selected infants under professional supervision
Evidence for the therapeutic value of evening primrose oil remains inconclusive
PUVA or UVB may be helpful in selected patients

Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to StumbleUpon StumbleUpon Add to Technorati Technorati What's this?

Relevant Article

Childhood eczema: Miriam Santer, Sue Lewis-Jones, and Tom Fahey
BMJ 2005 331: 497. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

Hindley, D, Galloway, G, Murray, J, Gardener, L (2006). A randomised study of "wet wraps" versus conventional treatment for atopic eczema. Arch. Dis. Child. 91: 164-168 [Abstract] [Full text]
Santer, M., Lewis-Jones, S., Fahey, T. (2005). Childhood eczema. BMJ 331: 497-497 [Full text]
Williams, H. C. (2005). Atopic Dermatitis. NEJM 352: 2314-2324 [Full text]
Flohr, C., Williams, H. C (2004). Evidence based management of atopic eczema. EDUCATION AND PRACTICE 89: ep35-ep39 [Full text]
Kobayashi, H., Takahashi, K., Mizuno, N., Kutsuna, H., Ishii, M. (2004). An Alternative Approach to Atopic Dermatitis: Part II--Summary of Cases and Discussion. Evid Based Complement Alternat Med 1: 145-155 [Abstract] [Full text]
(2003). Topical steroids for atopic dermatitis in primary care. DTB 41: 5-8 [Abstract] [Full text]
Thomas, K S, Armstrong, S, Avery, A, Po, A L. W., O'Neill, C, Young, S, Williams, H C (2002). Randomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema. BMJ 324: 768-768 [Abstract] [Full text]
Williams, H., Adetugbo, K., Po, A. L. W., Naldi, L., Diepgen, T., Murrell, D. (1998). The Cochrane Skin Group: Preparing, Maintaining, and Disseminating Systematic Reviews of Clinical Interventions in Dermatology. Arch Dermatol 134: 1620-1626 [Abstract] [Full text]
(1995). Allergen testing in patients with type I hypersensitivity. DTB 33: 45-47 [Abstract] [Full text]